STOCK TITAN

Form 4: Kyriakakis Christopher reports multiple insider transactions in ZION

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Kyriakakis Christopher reported multiple insider transaction types in a Form 4 filing for ZION. The filing lists transactions totaling 11,754 shares at a weighted average price of $60.22 per share. Following the reported transactions, holdings were 39,119 shares.

Positive

  • None.

Negative

  • None.

Insights

Routine equity grant with tax withholding; no major governance impact.

The filing shows Christopher Kyriakakis, EVP and Chief Risk Officer of Zions Bancorporation, receiving a grant of 10,917 common shares at $60.19 on February 12, 2026. This is characterized as a grant, award, or other acquisition.

Two small transactions on February 12–13, 2026 totaling 837 shares are coded "F", meaning shares were disposed to cover tax obligations, not sold on the open market. Afterward, he directly owned 39,119.348 shares, indicating continued alignment with shareholders.

These events represent standard executive compensation and tax handling rather than a strategic shift. They are unlikely to materially alter an informed investor’s view; subsequent company filings may provide broader performance or compensation context.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kyriakakis Christopher

(Last) (First) (Middle)
ONE SOUTH MAIN STREET, 11TH FLOOR

(Street)
SALT LAKE CITY UT 84133-1109

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ [ ZION ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP - Chief Risk Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/12/2026 F 473 D $60.19 28,566.348 D
Common Stock 02/12/2026 A 10,917 A $60.19 39,483.348 D
Common Stock 02/13/2026 F 364 D $61.26 39,119.348 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
By Rena Miller as attorney in fact 02/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did ZION executive Christopher Kyriakakis report?

Christopher Kyriakakis reported receiving 10,917 Zions Bancorporation (ZION) common shares as a grant at $60.19 on February 12, 2026. He also reported two small tax-withholding dispositions totaling 837 shares, leaving him with 39,119.348 shares held directly afterward.

Did the ZION executive sell shares on the open market in this Form 4?

The Form 4 for Zions Bancorporation (ZION) shows no open-market sales. The 473 and 364 shares reported as disposed are coded “F,” meaning they were used to pay tax liabilities or exercise costs, a common administrative step with stock-based compensation.

How many ZION shares does Christopher Kyriakakis own after these transactions?

After the reported transactions, Christopher Kyriakakis directly owns 39,119.348 shares of Zions Bancorporation (ZION) common stock. This figure reflects the large equity grant he received on February 12, 2026, minus the small number of shares withheld for tax obligations.

What was the size of the equity grant to the ZION Chief Risk Officer?

The Zions Bancorporation (ZION) Chief Risk Officer, Christopher Kyriakakis, received an equity grant of 10,917 common shares at $60.19 per share on February 12, 2026. This transaction is coded as an acquisition related to a grant, award, or other form of stock-based compensation.

What do the “F” transaction codes mean in the ZION Form 4 filing?

In this Zions Bancorporation (ZION) Form 4, the “F” codes indicate 473 and 364 shares were disposed to satisfy tax liabilities or exercise costs. These transactions are classified as tax-withholding dispositions, not discretionary open-market sales by the executive.

Who is the reporting person in the ZION Form 4 and what is his role?

The reporting person is Christopher Kyriakakis, an officer of Zions Bancorporation (ZION) serving as Executive Vice President and Chief Risk Officer. The Form 4 details his recent equity award and related share dispositions used to cover associated tax obligations.
Zions Bancorporation N A

NASDAQ:ZION

ZION Rankings

ZION Latest News

ZION Latest SEC Filings

ZION Stock Data

9.16B
144.89M
Banks - Regional
National Commercial Banks
Link
United States
SALT LAKE CITY